What conditional approval would mean for a dog drug
It lets a vet prescribe a drug before its long trial is finished, for a year at a time and five years at most, and only exactly as the label says.
Why it exists
Proving a drug adds years to a dog's life takes years. Conditional approval lets a company sell an animal drug once it has shown a "reasonable expectation of effectiveness", before the full proof is in. Safety and manufacturing still have to meet the same standard as a full approval (FDA).
The route began in 2004 for minor uses and minor species. Since 2018 it has also covered dogs, cats and horses, for serious conditions or unmet needs where proving effectiveness takes complex or particularly difficult studies (FDA, FDA guidance).
How long it lasts
One year at a time, renewed each year up to four times, so five years in all. Each renewal needs the company to show it is making progress toward full approval. If the full evidence is sent in by four and a half years, the approval runs six more months while the FDA reviews it; otherwise it ends at five (FDA). For LOY-002 the full evidence is the STAY study.
What the label says
The box must say "Conditionally approved by FDA pending a full demonstration of effectiveness" with the application number. And unlike most vet medicines, a conditionally approved drug may not be used in any other way than its label directs: no other ages, sizes or species (FDA). If LOY-002's label says dogs of 10 and over, a vet could not give it to a 9-year-old.
Whether your dog should take any of these is a question for your vet, who knows its health.
Sources
- Conditional approval explained, a resource for veterinarians, FDA, May 11, 2026.
- FDA issues draft guidance on expanded conditional approval of certain animal drugs, FDA, July 13, 2021.
- CVM GFI #261, eligibility criteria for expanded conditional approval, FDA, July 13, 2021.